Transdermal progesterone cream as an alternative progestin in hormone therapy.
暂无分享,去创建一个
[1] J. Eden,et al. Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women , 2003, Menopause.
[2] Heidi D Nelson,et al. Postmenopausal hormone replacement therapy: scientific review. , 2002, JAMA.
[3] P. Elder,et al. Caution on the use of saliva measurements to monitor absorption of progesterone from transdermal creams in postmenopausal women. , 2002, Maturitas.
[4] S. Evans,et al. Salivary, but not serum or urinary levels of progesterone are elevated after topical application of progesterone cream to pre‐and postmenopausal women , 2000, Clinical endocrinology.
[5] N. Watson,et al. Comparison of the pharmacokinetics of crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women(3). , 2000, Fertility and sterility.
[6] J. Eden,et al. Effect of sequential transdermal progesterone cream on endometrium, bleeding pattern, and plasma progesterone and salivary progesterone levels in postmenopausal women , 2000, Climacteric : the journal of the International Menopause Society.
[7] S. Longo,et al. Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. , 1999, Obstetrics and gynecology.
[8] K. Hermsmeyer,et al. Percutaneous absorption of progesterone in postmenopausal women treated with transdermal estrogen. , 1999, American journal of obstetrics and gynecology.
[9] D. Ross,et al. Systemic absorption of progesterone from Progest cream in postmenopausal women , 1998, The Lancet.
[10] J. Studd,et al. Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. , 1997, Human reproduction update.
[11] J. Simon. Micronized progesterone: vaginal and oral uses. , 1995, Clinical obstetrics and gynecology.
[12] C. Nappi,et al. Endometrial hyperplasia: efficacy of a new treatment with a vaginal cream containing natural micronized progesterone. , 1994, Maturitas.
[13] J. Woodruff,et al. Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group. , 1994, American journal of obstetrics and gynecology.
[14] A. Lethaby,et al. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding. , 2004, The Cochrane database of systematic reviews.
[15] H. B. Leonetti,et al. Topical progesterone cream has an antiproliferative effect on estrogen-stimulated endometrium. , 2003, Fertility and sterility.
[16] D. Miron,et al. Pharmacokinetics of progesterone in postmenopausal women: 2. Pharmacokinetics following percutaneous administration. , 1998, European journal of drug metabolism and pharmacokinetics.